Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
Front Immunol
; 12: 817893, 2021.
Article
in En
| MEDLINE
| ID: mdl-35111167
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Postoperative Care
/
Scleroderma, Systemic
/
Antirheumatic Agents
/
Rituximab
Type of study:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Front Immunol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: